Evaluation of the ovarian reserve function in patients with metabolic syndrome in relation to healthy controls and different age groups

Table 1 Demographic characteristics, anthropometrics and laboratory findings in study groups

	Study groups according to age									Total (n = 136)
	20–29 years (n = 49)			30–39 years (n = 45)			40–49 years (n = 42)			Total (n = 136)
	MetS (n = 22)	Control (n = 27)	p value	MetS (n = 22)	Control (n = 23)	p value	MetS (n = 23)	Control (n = 19)	p value	MetS (n = 67)	Control (n = 69)	p value
Age (yr)	24.0 ± 5.1	23.9 ± 3.8	0.900	34.1 ± 3.1	33.7 ± 2.9	0.700	42.5 ± 2.9	43.1 ± 2.8	0.48	33.7 ± 8.2	32.5 ± 8.5)	0.376
BMI (kg/m²)	34.1 ± 5.6	23.8 ± 4.4	<0.001	35.9 ± 5.8	28.1 ± 3.2	<0.001	38.1 ± 5.2	30.5 ± 4.1	<0.001	36.1 ± 5.7	27.1 ± 4.8	<0.001
WC (cm)	110.8 ± 11.6	83.8 ± 11.0	<0.001	107.2 ± 14.4	86.3 ± 9.7	<0.001	108.9 ± 13.9	91.6 ± 13.1	<0.001	106.0 ± 13.1	83.8 ± 12.3	<0.001
HOMA-IR	3.6 ± 1.7	2.2 ± 1.3	0.002	3.7 ± 1.8	2.2 ± 1.4	0.005	3.4 ± 1.3	2.4 ± 1.3	0.020	3.7 ± 1.6	2.3 ± 1.3	0.268
FBG (mg/dl)	92.7 ± 5.5	88.9 ± 6.8	0.043	97.2 ± 13.5	92.2 ± 9.0	0.150	94.5 ± 10.3	94.5 ± 9.2	0.980	94.8 ± 10.3	91.6 ± 8.5	0.049
TG (mg/dl)	135.2 ± 74.7	104.0 ± 28.8	0.052	169.0 ± 65.3	119.1 ± 32.7	0.002	173.8 ± 87.7	118.3 ± 61.1	0.020	159.6 ± 77.5	113.0 ± 41.3	<0.001
HDL-C (mg/dl)	41.2 ± 12.4	51.3 ± 9.5	0.002	41.9 ± 12.2	48.0 ± 10.2	0.080	39.4 ± 7.1	49.3 ± 11.2	0.001	40.8 ± 10.8	49.7 ± 10.2	<0.001
Insulin (IU/ml)	15.9 ± 7.3	10.1 ± 5.4	0.002	14.8 ± 5.5	9.8 ± 5.5	0.005	14.5 ± 4.5	10.3 ± 5.6	0.010	15.1 ± 5.9	10.1 ± 5.4	<0.001

Data are shown as Mean (SD). BMI: Body mass index; FBG: fasting blood glucose; HDL-C: high density lipoprotein cholesterol; MetS: metabolic syndrome; TG: triglyceride; WC: waist circumference; WHR: waist to hip ratio.

ISSN: 1757-2215